IxMP – A Potential Second or Third Line Chemotherapy- On The Horizon
Can IxMP Be Used as a Second or Third-Line Chemotherapy for Metastatic Castrate Resistant Prostate Cancer? There was a report recently released about a Phase 2 study from the Department of Defense funded Prostate Cancer [...]
Some Good News, The Funding for the DOD Prostate Cancer Program is On Track!
There is some good budgetary news as it now appears that the CDMRP (the Department of Defense) programs, including the Peer Reviewed Prostate Cancer Program, are funded at the omnibus level (last year’s level). The [...]
Disease Risk, Not Age, Should Influence Prostate Cancer Treatment Decisions
Should treatments offered to older men with high risk prostate cancer be different than for younger men? Researchers from the University of California, San Francisco found that older men were denied more aggressive treatments because [...]
One Large Step for Prostate Cancer and One Very Small Step for Men – Whole Genome Sequencing for Prostate Cancer
Yesterday the Prostate Cancer Foundation (PCRF) made a major announcement, it has sequenced the of whole cancer genomes of seven different men with aggressive prostate cancer. This is a historic development in the fight against [...]
One Man’s Experience Fighting The Side Effects of Jevtana (Cabaziltaxel)
A member of the advanced prostate cancer on-line group recently posted about his experience using the newly approved chemotherapy agent, Jevtana (cabazitaxel). His post included not only a report about his PSA response to the [...]
Current Update on the Abiraterone Expanded Access Trial
The latest from Jan Manarite of PCRI about the getting early access to Abiraterone for men with advanced prostate cancer and who have failed chemotherapy: Abiraterone expanded Access Trial Site Contact Info – 2/7/11 (800) [...]